Stock Events

Stock Events

Mangoceuticals 

$0.2334
38
+$0.00+1.48% 07:05 Today

Statistics

Day High
0.2334
Day Low
0.23
52W High
0.5449
52W Low
0.2239
Volume
1,285
Avg. Volume
-
Mkt Cap
5.19M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Financials

-4,784.87%Profit Margin
Unprofitable
2021
2022
2023
2024
2025
456,000Revenue
-21.82MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow MGRX.BOATS. It's not an investment recommendation.
Apple
5
AAPL
Starbucks
5
SBUX
Rocket Lab
5
RKLB
Grab Limited
5
GRAB

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Pfizer
PFE
Mkt Cap173.95B
Pfizer is a global pharmaceutical company that competes with Mangoceuticals in the development and marketing of medications across various therapeutic areas.
Merck
MRK
Mkt Cap368.89B
Merck operates in the pharmaceutical sector, directly competing with Mangoceuticals in research, development, and distribution of drugs for various diseases.
Johnson & Johnson
JNJ
Mkt Cap657.68B
Johnson & Johnson, through its pharmaceutical segment, competes with Mangoceuticals in producing drugs for a wide range of medical conditions.
Abbvie
ABBV
Mkt Cap521.11B
AbbVie competes in the biopharmaceutical field, focusing on therapeutic areas similar to Mangoceuticals, making it a direct competitor.
AMGEN
AMGN
Mkt Cap251.94B
Amgen is a biotech company that competes with Mangoceuticals in the development of innovative therapies and medications.
Gilead Sciences
GILD
Mkt Cap211.7B
Gilead Sciences is involved in the discovery, development, and commercialization of medicines in areas overlapping with Mangoceuticals' interests.
Bristol-Myers Squibb
BMY
Mkt Cap127.71B
Bristol Myers Squibb is a global biopharmaceutical company that competes with Mangoceuticals in developing and selling prescription pharmaceuticals in several therapeutic areas.
Novartis
NVS
Mkt Cap303.67B
Novartis is a multinational pharmaceutical company that competes with Mangoceuticals in researching and marketing drugs for various health conditions.
Roche
RHHBY
Mkt Cap334.28B
Roche Holding AG competes with Mangoceuticals through its strong focus on pharmaceuticals and diagnostics for complex diseases.
Astrazeneca
AZN
Mkt Cap289.48B
AstraZeneca is a global, science-led biopharmaceutical business that competes with Mangoceuticals in developing and commercializing prescription medicines.

About

Mangoceuticals Inc focuses on developing, marketing, and selling a variety of men's wellness products and services through a telemedicine platform. The company's platform provides access for customers to a licensed pharmacy for online fulfillment and distribution of certain medications that may be prescribed as part of telehealth consultations, including Mango ED products.
Show More
CEO
ISIN
US56270V2051

Listings

XNAS
US
MGRX
BOATS
BOATS
MGRX.BOATS

0 Comments

Share your thoughts

FAQs

What is Mangoceuticals stock price today?▼
The current price of MGRX.BOATS is $0.23 USD — it has increased by +1.48% in the past 24 hours. Watch Mangoceuticals stock price performance more closely on the chart.
What is Mangoceuticals stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on Boats exchange Mangoceuticals stocks are traded under the ticker MGRX.BOATS.
What is Mangoceuticals market cap?▼
Today Mangoceuticals has the market capitalization of 5.19M
What is Mangoceuticals revenue for the last year?▼
Mangoceuticals revenue for the last year amounts to 456,000 USD.
What is Mangoceuticals net income for the last year?▼
MGRX.BOATS net income for the last year is -21.82M USD.
In which sector is Mangoceuticals located?▼
Mangoceuticals operates in the Other sector.
When did Mangoceuticals complete a stock split?▼
The last stock split for Mangoceuticals was on October 16, 2024 with a ratio of 1:15.